RLMD - Relmada Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.94 0.11 (5.67%)	---	---	---	0.02 (1.03%)	0.12 (6.22%)	0.0 (0.0%)	-0.01 (-0.51%)

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.3
Diluted EPS:: -0.3
Basic P/E:: -6.8333
Diluted P/E:: -6.8333
RSI(14) 1m:: 60.0
VWAP:: 2.04
RVol:: 0.6205

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.04 -0.03 (-1.45%)	Oct 15 15:58
1m	Price decrease 1m	2.04 -0.03 (-1.45%)	Oct 15 15:56
1m	Price decrease 1m	1.98 -0.02 (-1.0%)	Oct 15 14:55
1m	Price increase 1m	2.02 +0.02 (+1.21%)	Oct 15 14:08
1m	Price decrease 1m	2.01 -0.03 (-1.23%)	Oct 15 13:55